Fifty-five percent of physicians do not plan to attest for meaningful use Stage 2 in 2015, according to a recent poll done by Medical Practice Insider and SERMO, a social network exclusively for doctors.
The poll consisted of nearly 2,000 physicians revealed that doctors are opting to forego Stage 2 by a margin of 994 to 822 participants. The survey consisted of one simple yes-or-no question: Do you plan to attest for Stage 2 in 2015?
Individual comments from surveyed SERMO members show a variety of reasons—some financially motivated, others not—for physicians deciding that they've had enough with the meaningful use program and will go no further. However, many of these comments came from specialists, a collective that often faces unique meaningful use challenges—particularly when it comes to core, menu and clinical quality measures engineered for providers with a broader swath of patients and services, making it easier to fulfill those requirements, according to Medical Practice Insider.
According to recent Centers for Medicare and Medicaid Services (CMS) data, fewer than 35 percent of the nation’s hospitals have met Stage 2 meaningful use requirements, and only four percent of eligible professionals (EPs) have demonstrated achievement of Stage 2 objectives.
While stolen financial data still has a higher market value than stolen medical records, as financial data can be monetized faster, there are indications that there is ongoing development of a market for stolen medical data, according to an Intel Security McAfee Labs report.
A phishing scam at Baystate Health in Springfield, Mass. has potentially exposed the personal data of 13,000 patients, according to a privacy statement from the patient care organization and a report from MassLive.
In an update, DirectTrust reported significant growth in Direct exchange of health information and the number of trusted Direct addressed enabled to share personal health information (PHI) in the third quarter of 2016.
Eleven private insurers, including Aetna, Humana and Anthem, are urging the Congressional Budget Office (CBO) to consider the experience of commercial insurers when evaluating the impact of telemedicine coverage in Medicare.
With the aim of improving patient safety monitoring, the Agency for Healthcare Research and Quality (AHRQ) within the U.S. Department of Health and Human Services (HHS) is currently developing and testing an improved patient safety surveillance system.